Overview

  • Product nameMaprotiline hydrochloride
  • Description
    Noradrenaline reuptake inhibitor
  • Biological descriptionNoradrenaline reuptake inhibitor. KD values are 11.1, 1000 and 5800 nM for noradrenaline, dopamine and serotonin transporters, respectively. Demonstrates 98% bioavailability following oral administration. Antidepressant activity in vivo.
  • Purity> 99%

Properties

    References for Maprotiline hydrochloride (ab120769)

    This product has been referenced in:
    • Brachtendorf L  et al. Cytochrome P450 enzymes contributing to demethylation of maprotiline in man. Pharmacol Toxicol 90:144-9 (2002). Read more (PubMed: 12071336) »
    • Tatsumi M  et al. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-58 (1997). Read more (PubMed: 9537821) »
    • Baumann PA & Maître L Neurobiochemical aspects of maprotiline (Ludiomil) action. J Int Med Res 7:391-400 (1979). Read more (PubMed: 387493) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120769.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"